OCTRI announces new Biomedical Innovation Program award recipients

The Oregon Clinical & Translational Research Institute is pleased to announce the funding of five research awards through its Biomedical Innovation Program. The Program funds promising translational projects with the goal of moving innovative technologies to clinical application through commercialization. The Biomedical Innovation Program is supported by major funding from OCTRI, with supplemental support from the Oregon Translational Research and Development Institute (OTRADI), and by a strong collaboration with OHSU Technology Transfer and Business Development.

Congratulations to our 2013 Biomedical Innovation Pilot Award Winners:

  • Nerve-Specific Fluorophores to Guide Nerve-Sparing Prostatectomy, Summer Gibbs, Ph.D.
  • Electronic Device to Prevent Central Line Infections, Michael Hutchens, M.D., M.A.
  • Designing a Convenient and Precise Device for Home Dried Blood Spot Collection, Dennis Koop, Ph.D., Andrew Chitty, MBA and Amira Al Uzri, M.D.
  • Development of a Urine Based Bladder Cancer Recurrence Diagnostic Using a Genomic Disease Signature, Theresa Koppie, M.D.
  • Bio-Absorbable Clip for Watertight Closure of Human Tissues, Neil Roundy, M.D.

“The Biomedical Innovation program gives OHSU faculty a new outlet for great new biomedical device ideas,” said OCTRI Director Eric Orwoll, M.D. “These projects have real potential to improve medical care as well as to set the stage for additional novel research directions.”

For more detailed information on all five awards, including project abstracts is provided on the OCTRI website.

For more information on OCTRI’s services, please visit: www.octri.org

OCTRI is supported by (UL1TR000128) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH).